Back to Millennium Management LLC Millennium Management LLC

TRVITRVI

Showing 8 of 19 quarters

Position history for Millennium Management LLCMillennium Management LLC's holdings in Trevi Therapeutics, Inc.

No. Millennium Management exited its TRVI (Trevi Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 570,971 shares worth $6.8M. Millennium Management first reported TRVI in Q2 2019 and held it in 15 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$68,874

Total Shares Change

-20,621

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$18.65
0
2026-Q1
Increased
570,971
+0.1%
$6.8M0.0%$12.26
27
2025-Q4
Decreased
570,226
-21.6%
$7.1M0.0%$12.52
0
2025-Q3
Increased
727,596
+362.7%
$6.7M0.0%$9.15
44
2025-Q2
Decreased
157,244
-80.9%
$860,1250.0%$5.47
0
2025-Q1
Increased
823,249
+356.3%
$5.2M0.0%$6.29
44
2024-Q4
Increased
180,419
+774.9%
$743,3260.0%$4.12
40
2024-Q3
New
20,621
—
$68,8740.0%$3.33
32

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used